RA Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105M	Hold	23,555,648	–	–	1.12%	21
2025 Q4	$130M	Hold	23,555,648	–	–	1.33%	17
2025 Q3	$77M	Hold	23,555,648	–	–	0.95%	27
2025 Q2	$54.4M	Buy	23,555,648 +12,683,145	+117%	+$27.6M	0.92%	25
2025 Q1	$15.1M	Hold	10,872,503	–	–	0.25%	55
2024 Q4	$18.8M	Hold	10,872,503	–	–	0.25%	58
2024 Q3	$21.9M	Hold	10,872,503	–	–	0.25%	53
2024 Q2	$24.4M	Hold	10,872,503	–	–	0.32%	48
2024 Q1	$31.2M	Sell	10,872,503 -7,600,000	-41%	-$15.8M	0.4%	50
2023 Q4	$32.7M	Hold	18,472,503	–	–	0.51%	38
2023 Q3	$58.4M	Buy	+18,472,503	New	+$34.5M	1.15%	25